ASCO/AACR Experts Advocate for E-Cigarette Regulations
January 8, 2015
Experts from ASCO and AACR have penned a statement for policymakers on the potential negative effects of e-cigarettes and other nicotine-deliveries electronics.
Practice & Policy
Febrile Neutropenia Costly Problem in Metastatic Cancer
December 17, 2014
Risk for febrile neutropenia was high among patients with metastases from a variety of common cancers and was associated with numerous clinical and economic consequences, including increased morbidity and mortality.
What We Can Learn From Our Patients
December 16, 2014
Patient satisfaction data can give practices insight into their operations and make specific, practice-level adjustments accordingly, and with aggregated data we can gain insights into global practice responsiveness and patient perceptions regarding care.
Guide Helps Oncologists Fit Shared Decision-Making Into Everyday Practice
December 3, 2014
A panel of experts has put together a guide to implementing shared decision-making that provides tips for integrating the model into busy oncology practices.
ASCO: Reform Medicaid to Improve Cancer Care for Low-Income Patients
November 20, 2014
ASCO is calling for major reforms to the Medicaid system in order to close gaps in cancer coverage and improve quality of care for low-income Americans.
National Lung Screening Trial Limitations and Public Health Policy
November 15, 2014
NLST data clearly demonstrate that lung cancer screening is effective and safe and reduces lung cancer-specific mortality by at least 20%. There is no possible reason for CMS to further delay or restrict lung cancer screening for those at high risk.
CT Lung Cancer Screening: Public Healthcare Policy and Guidelines Collide
November 15, 2014
The development of CT lung cancer screening, the publication of results from the NLST in 2011, and the grade-B recommendation for CT lung cancer screening in high-risk smokers by the USPSTF raise a number of interesting national health policy issues.
The Time for Low-Dose Computed Tomography Screening Is Now: A Medical Oncologist Perspective
November 15, 2014
The NLST is a landmark trial demonstrating that implementation of low-dose CT screening lowers lung cancer–related mortality. We must put the study results and cost-effectiveness analyses in the context of the staggering statistics: up to 65% of lung cancer patients present with advanced-stage disease where treatments are often costly, toxic, and only palliative in nature.
Assumption of Risk, Healthcare Policy, and Cancer Screening
November 15, 2014
American medicine is poised for an expanded conflict over the assumption and consequences of risk in medical care.
Medicare Will Cover Lung Cancer Screening
November 12, 2014
The Centers for Medicare & Medicaid Services announced plans to cover low-dose CT screening for lung cancer, based mainly on the National Lung Screening Trial.
